Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017, Article ID 5326909, 8 pages
https://doi.org/10.1155/2017/5326909
Research Article

Genome-Wide Profiling Reveals That Herbal Medicine Jinfukang-Induced Polyadenylation Alteration Is Involved in Anti-Lung Cancer Activity

1Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, College of Life Sciences, Northwest University, 229 Taibai Road, Xi’an 710069, China
2Shanghai Center for Systems Biomedicine, School of Biomedical Engineering, State Key Laboratory on Oncogene and Bio-ID Center, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai 200240, China

Correspondence should be addressed to Jing Tian; nc.ude.uwn@gnijnait

Received 6 April 2017; Revised 15 June 2017; Accepted 13 September 2017; Published 1 November 2017

Academic Editor: Oliver Micke

Copyright © 2017 Yao Kou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Shi, “Alternative polyadenylation: New insights from global analyses,” RNA, vol. 18, no. 12, pp. 2105–2117, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. E. Wahle and W. Keller, “The biochemistry of 3-end cleavage and polyadenylation of messenger RNA precursors,” Annual Review of Biochemistry, vol. 61, pp. 419–438, 1992. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Rehfeld, M. Plass, A. Krogh, and L. Friis-Hansen, “Alterations in polyadenylation and its implications for endocrine disease,” Frontiers in Endocrinology, vol. 4, 53 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Mayr and D. P. Bartel, “Widespread shortening of 3UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells,” Cell, vol. 138, no. 4, pp. 673–684, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Elkon, A. P. Ugalde, and R. Agami, “Alternative cleavage and polyadenylation: Extent, regulation and function,” Nature Reviews Genetics, vol. 14, no. 7, pp. 496–506, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Volinia, G. A. Calin, C. G. Liu et al., “A microRNA expression signature of human solid tumors defines cancer gene targets,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 103, no. 7, pp. 2257–2261, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Lin, Z. Li, F. Ozsolak et al., “An in-depth map of polyadenylation sites in cancer,” Nucleic Acids Research, vol. 40, no. 17, pp. 8460–8471, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. R. L. Siegel, K. D. Miller, and A. Jemal, “Cancer statistics, 2016,” CA: A Cancer Journal for Clinicians, vol. 66, no. 1, pp. 7–30, 2016. View at Publisher · View at Google Scholar
  9. B. R. Cassileth, N. Rizvi, G. Deng et al., “Safety and pharmacokinetic trial of docetaxel plus an Astragalus-based herbal formula for non-small cell lung cancer patients,” Cancer Chemotherapy and Pharmacology, vol. 65, no. 1, pp. 67–71, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Ramesh, “Drug resistance in lung cancer,” Lung Cancer: Targets and Therapy, pp. 23–36, 2010. View at Publisher · View at Google Scholar
  11. R. Han, “Highlight on the studies of anticancer drugs derived from plants in China,” Stem Cells, vol. 12, no. 1, pp. 53–63, 1994. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Liu and Z. Shi, “Clinical study on treating non-small cell lung carcinoma with JinFuKang oral liquid,” Journal of Traditional Chinese Medicine, vol. 38, no. 12, p. 727, 1997. View at Google Scholar
  13. J. Liu, M. Pan, and Y. Li, “Clinical study of oral liquid Jin Fu Kang for the treatment of primary non-small cell lung cancer,” Tumor (Shanghai), vol. 21, no. 6, pp. 463–465, 2001. View at Google Scholar
  14. L. Jiao, Y. Wang, L. Xu, and M. You, “Lung cancer prevention and therapy using the JinFuKang herbal mixture,” Current Pharmacology Reports, vol. 1, no. 5, pp. 346–353, 2015. View at Publisher · View at Google Scholar
  15. S. J. Liu and J. L. Sun, “Effect of Jinfukang oral solutionon expression of apoptosis related genes of human lung adenocarcinoma cells transplanted in nude mice,” Shanghai Journal of Traditional Chinese Medicine, vol. 10, pp. 69–71, 2007. View at Google Scholar
  16. J. Lu, X. Zhang, T. Shen et al., “Epigenetic profiling of H3K4Me3 reveals herbal medicine jinfukang-induced epigenetic alteration is involved in anti-lung cancer activity,” Evidence-Based Complementary and Alternative Medicine, vol. 2016, Article ID 7276161, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. D.-P. Lai, S. Tan, Y.-N. Kang et al., “Genome-wide profiling of polyadenylation sites reveals a link between selective polyadenylation and cancer metastasis,” Human Molecular Genetics, vol. 24, no. 12, pp. 3410–3417, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. B. Langmead, C. Trapnell, M. Pop, and S. L. Salzberg, “Ultrafast and memory-efficient alignment of short DNA sequences to the human genome,” Genome Biology, vol. 10, no. 3, article R25, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Tian, J. Hu, H. Zhang, and C. S. Lutz, “A large-scale analysis of mRNA polyadenylation of human and mouse genes,” Nucleic Acids Research, vol. 33, no. 1, pp. 201–212, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Mi, A. Muruganujan, J. T. Casagrande, and P. D. Thomas, “Large-scale gene function analysis with the PANTHER classification system.,” Nature Protocols, vol. 8, no. 8, pp. 1551–1566, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Fu, Y. Sun, Y. Li et al., “Differential genome-wide profiling of tandem 3 UTRs among human breast cancer and normal cells by high-throughput sequencing,” Genome Research, vol. 21, no. 5, pp. 741–747, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. F. Ma, C. Zhang, K. V. S. Prasad, G. J. Freeman, and S. F. Schlossman, “Molecular cloning of porimin, a novel cell surface receptor mediating oncotic cell death,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 98, no. 17, pp. 9778–9783, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Lu, J. Chen, N. Xu et al., “Activation of AIFM2 enhances apoptosis of human lung cancer cells undergoing toxicological stress,” Toxicology Letters, vol. 258, pp. 227–236, 2016. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Li, X. Chen, Y. Yao, and W. Ren, “A study of JinFuKang in the treatment of liver cancer,” Chinese Traditional Herbal Drugs, vol. 31, no. 7, p. 533, 2000. View at Google Scholar